Top line results of a large phase 4 study with saxagliptin (Onglyza, Bristol-Myers Squibb and AstraZeneca) demonstrate that the drug is safe but has no cardiovascular benefits. AstraZeneca and... Read More
from Forbes Real Time
An AstraZeneca And Bristol-Myers Diabetes Trial Is A Dud
Today 13:25 EDT
In a setback to an important joint venture between Bristol-Myers Squibb and AstraZeneca, the top-line results of a large, late-stage study of their Onglyza diabetes drug failed to show superiority in... Read More
from Forbes Real Time
Early Movers: FDX, ADBE DELL, BA, BBRY & More
Today 7:45 EDT
from CNBC.com News
Bristol-Myers (BMY), AstraZeneca (AZN) SAVOR-TIMI-53 Misses Primary Efficacy Endpoint in Phase 4
Today 6:20 EDT
LONDON, June 19 (Reuters) - AstraZeneca and Bristol-Myers Squibb's diabetes drug Onglyza failed to reduce heart risks in a large clinical study, disappointing investors who had thought it might... Read More
category
companyNews
LONDON, June 19 (Reuters) - AstraZeneca and Bristol-Myers Squibb's diabetes drug Onglyza failed to reduce heart risks in a large clinical study. Read More
category
companyNews
Medtronic Saga: Corrupt Science, Belated Warning
June 18, 2013
from YCharts
The NIH Aims To Develop Drugs That Big Pharma Discarded
June 18, 2013
This morning, the National Institutes of Health awarded $12.7 million to nine academic groups to test potential medicines for diseases including Alzheimer's disease, Duchenne muscular dystrophy, and... Read More
from Forbes Real Time
category
companyNews
LONDON, June 18 (Reuters) - AstraZeneca has chosen a science park in Cambridge, England, next to the world-renowned Addenbrooke's Hospital, as its new $500 million global headquarters and centre of... Read More
category
companyNews
Pharma Stocks: Court Ruling's Real Meaning
June 17, 2013
from YCharts
from PR Newswire
BRIEF-AstraZeneca's MedImmune, NGM Biopharmaceuticals in deal to develop therapies for diabetes and obesity
June 17, 2013
LONDON, June 17 (Reuters) - AstraZeneca PLC : * Medimmune,NGM Biopharmaceuticals announce agreement to discover and develop Read More
category
companyNews
Roche (RHHBY) recently announced that the US Food and Drug Administration (FDA) has approved... Visit StockBlogHub to view complete post. Read More
from Stock Blog Hub
LONDON, June 14 (Reuters) - British drugmaker AstraZeneca is deepening its collaboration with academia by roping in more outside researchers to help to find new cancer drugs. Read More
category
companyNews
NEW YORK, June 12 (Reuters) - Global drugmakers said on Wednesday they would cooperate with an independent review to address concerns of a potential link between widely used diabetes medicines and... Read More
category
companyNews
from PR Newswire
Is M&A Mania Poised to Keep Fanning the Market’s Flames?
June 12, 2013
Combining Therapies to Amplify the Effects of Statins
June 11, 2013
from ACCESSWIRE
PRESS DIGEST - British Business - June 11
June 10, 2013
June 11 (Reuters) - The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy. Read More
category
companyNews
Benzinga's M&A Chatter for Monday June 10, 2013
June 10, 2013
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here